Table 5. Utilization of Genetic Testing Information.
Table reflects percentages of patients who answered “yes” to “Did your genetic test results play a role in your decision to do any of the following?”
| Positive n = 11 (%) | VUS n = 14 (%) | Negative n = 104 (%) | ||
|---|---|---|---|---|
| Personal history of breast or ovarian cancer | Type of surgery to treat breast cancer (mastectomy vs. lumpectomy) | 4 (36.4) | 2 (14.3) | 17 (16.4) |
| Receive radiation | 2 (18.2) | 2 (14.3) | 13 (12.5) | |
| Receive chemotherapy | 1 (9.1) | 2 (14.3) | 13 (12.5) | |
| Receive another type of treatment | 2 (18.2) | 1 (7.1) | 9 (8.7) | |
| Change treatment | 1 (9.1) | 1 (7.1) | 2 (1.9) | |
| Stop treatment | 0 (0.0) | 1 (7.1) | 3 (2.9) | |
| Have prophylactic surgery | 2 (18.2) | 1 (7.1) | 11 (10.6) | |
| Receive a drug to prevent breast cancer | 1 (9.1) | 3 (21.4) | 16 (15.4) | |
| Have more frequent or additional cancer screening | 1 (9.1) | 3 (21.4) | 16 (15.4) | |
| Positive n = 14 (%) | VUS n = 20 (%) | Negative n = 69 (%) | ||
| No personal history of breast or ovarian cancer | Have prophylactic surgery | 1 (7.1) | 3 (15.0) | 7 (10.1) |
| Receive a drug to prevent breast cancer | 0 (0.0) | 1 (5.0) | 4 (5.8) | |
| Have more frequent or additional cancer screening | 13 (92.9) | 7 (35.0) | 11 (15.9) |